Navigation Links
Cosun and Avantium Announce Collaboration
Date:1/21/2009

AMSTERDAM, January 21 /PRNewswire/ -- Today, Royal Cosun and Avantium announced the start of their collaboration. The companies join forces to develop a specific process for the production of a new generation of bioplastics and biofuels from selected organic waste streams. Avantium is developing these bioplastics and biofuels under the name 'Furanics'.

Within the collaboration, Cosun will focus on the selection, isolation and purification of suitable components from agricultural waste streams. Avantium will continue to focus on the development of an efficient, chemically catalyzed production process. The duration of the first phase of the collaboration will be approximately two years. With positive results, the companies intend to scale-up the production technology and implement it on commercial scale.

The collaboration between Cosun and Avantium combines the complementary knowledge and expertise from two important Dutch economic sectors to achieve new, sustainable products and processes based on biomass.

Collaboration between agro and chemistry

"The further optimization of the value of our agricultural products is of great importance for our future," said Gert de Raaff, Director Corporate Development at Cosun. "Agricultural products and waste streams will increasingly be used as starting material for the production of chemicals and materials. For several years, Cosun has been active in developing and marketing these applications, focusing on high-grade products. An example is Carboxy Methyl Inulin, which is used as a sustainable additive in water treatment. The collaboration with Avantium for the development of Furanics perfectly matches the vision and developments at Cosun."

Tom van Aken, CEO at Avantium: "Our collaboration with Royal Cosun fits in perfectly with our strategy to produce Furanics from raw materials that do not compete with the food chain. With this approach, we clearly distinguish ourselves from existing bioplastics and biofuels production processes. By collaborating with Cosun, we gain access to organic waste streams and Cosun's proven expertise in processing agricultural feedstock."

Furanics

For a number of years, Avantium has been developing "Furanics", a new generation of bioplastics and biofuels. Furanics can be produced from biomass such as sugars and other carbohydrates. Avantium's Furanics bioplastics can be produced cheaper than oil-based plastics and they have attractive properties with the potential to replace traditional plastics in many existing applications. Avantium's Furanics biofuel program aims to develop a new generation of biofuels with both excellent properties (such as high energy density and mixability with conventional fuels) and competitive production costs.

Furanics are a sustainable alternative for materials and fuels that are currently produced from crude oil. By using Furanics, the dependence on crude oil decreases and CO2 emissions are reduced.

Note for the editors

About Cosun

Royal Cosun is an international group that develops, produces and sells natural foodstuffs and ingredients. Cosun carries a broad and versatile range of products, from sugar, inulin, alcohol and potato specialities to compound ingredients for use in bakery products, dairy products, soft drinks and the foodservice sector. The group also processes organic residues into products for non-food applications.

In all these markets, the Cosun businesses Suiker Unie, Sensus, Nedalco, Aviko, SVZ and Unifine Food & Bake Ingredients work closely with their customers and suppliers.

Royal Cosun was established as a cooperative of Dutch sugar beet growers more than 100 years ago. The cooperative currently has approximately 11,000 member/shareholders. Cosun has grown into a group with an average workforce of 4,300 and a turnover of some EUR 1.7 billion.

    For more information about Cosun
    Please visit the website:http://www.cosun.com

About Avantium

Avantium is a leading technology company specialized in the area of advanced high-throughput R&D. The company develops and commercializes Furanics, a next generation biofuels and bioplastics, and develops improved forms of existing drugs. Avantium has demonstrated the value and commercial potential of its unique technology and knowledge by collaborating with leading companies in the energy, chemical and pharmaceutical industry. Avantium's customer base for its R&D services and systems offering consists of more than 70 companies worldwide, including market leaders such as BP, Shell, Sasol, Pfizer and GSK. In 2008, the company generated revenues of approximately EUR 19 million. Avantium has around 140 employees; its offices and headquarters are based in Amsterdam, the Netherlands.

For more information about Avantium

Please visit the website: http://www.avantium.com


'/>"/>
SOURCE Avantium and Cosun
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Avantium Completes EUR 18 Million Financing Round
2. Immtech Announces Appointment of Virchow Krause as Independent Registered Public Accounting Firm
3. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
4. S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
5. Nile Therapeutics Announces Focus on CD-NP for Acute Heart Failure and Termination of 2NTX-99 Program
6. GeneNews announces management changes
7. ATS Medical Announces Formation of Cryoablation Surgical Advisory Board
8. Environmental Tectonics Corporation Announces the Sale of Two BARA-MED(R) XD Monoplace Hyperbaric Chambers
9. Varian, Inc. Announces First Quarter 2009 Preliminary Results
10. Varian, Inc. Announces Cost Reduction Plan
11. TechConnect World 2009 Announces January 28th Last Call for Speaker-Proposals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... 2017 , ... For the second time in three years, ... Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October 10th, ... mission is to change the trajectory of STEM education in America by dramatically ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
Breaking Biology News(10 mins):